New video program aims to ease symptoms for young cancer patients
NCT ID NCT05593016
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new program called SMILE that helps teens and young adults (ages 15-29) with advanced cancer manage symptoms like pain, fatigue, and emotional distress. The program includes four video sessions at home, teaching relaxation and coping skills. Researchers checked if the program was acceptable and practical for patients, with 75 participants including patients and caregivers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Symptom Management for Improved Physical and Emotional Wellbeing (SMILE) program
- What this could lead to
- If it works, this could provide a practical, home-based program to help young people with advanced cancer better manage pain, fatigue, and emotional distress.
- What could go wrong
- This is a small, early-stage study focused on feasibility, not effectiveness. The intervention may not prove helpful in larger trials or for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT AND YOUNG ADULT CANCER PATIENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke Cancer Institute
Durham, North Carolina, 27701, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A lifeline for cancer caregivers: can simple phone support reduce their stress?
- A digital lifeline: could Real-Time symptom tracking transform care for kids with advanced cancer?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Can a new nucleotide analogue boost cancer treatment?
- Can a cancer vaccine train the body to fight advanced tumors?
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?